ACR	American College of Rheumatology
AE	adverse event
AOSD	adult-onset Still’s disease
BD	Behçet's disease
CAPS	cryopyrin-associated periodic syndromes
CRP	C-reactive protein
DAS	disease activity score
DAS28	28-joint disease activity score
DIRA	deficiency in IL-1 receptor antagonist
DLQI	dermatology life quality index
DMARD	disease-modifying antirheumatic drug
eGFR	estimated glomerular filtration rate
EMA	European Medicines Agency
ESR	erythrocyte sedimentation rate
EULAR	European League Against Rheumatism
FDA	U.S. Food and Drug Administration
Fc	fragment crystallizable
FMF	familial Mediterranean fever
GC	glucocorticoid
GvHD	graft-versus-host disease
HAQ	health assessment questionnaire
HbA1c	hemoglobin A1c
HIDS	hyper-IgD syndrome
HiSCR	hidradenitis suppurativa clinical response
HS	hidradenitis suppurativa
IGA	investigator's global assessment
IL	interleukin
IL-1	receptor antagonist
mAb	monoclonal antibody
MAS	macrophage activation syndrome
MKD	mevalonate kinase deficiency
MWS	Muckle-Wells syndrome
NSAID	non-steroidal anti-inflammatory drug
PAPA	pyogenic arthritis, pyoderma gangrenosum and acne
PFAPA	periodic fever, aphthous stomatitis, pharyngitis, and adenitis
PDN	prednisone
PG	pyoderma gangrenosum
PGA	patient global assessment
PsARC	psoriasis arthritis response criteria
QoL	quality of life
RA	rheumatoid arthritis
RCT	randomized controlled trial
SAA	serum amyloid A
SAE	serious adverse event
SAPHO	synovitis, acne, pustulosis, hyperhidrosis, osteitis
SC	subcutaneous(ly)
SF-36	36-Item Short Form Survey
sJIA	systemic juvenile idiopathic arthritis
SjS	Sjögren’s syndrome
SLE	systemic lupus erythematosus
T1DM	type 1 diabetes mellitus
TNF	tumor necrosis factor
TRAPS	TNF receptor-associated periodic syndrome
UVAS	urticarial vasculitis activity score
VAS	visual acuity score